This is a paid press release. Contact the press release distributor directly with any enquiries.
Global Markets for Fermentation Ingredients to Reach $53.4 Billion by 2031, Driven by Rising Demand for Animal Nutrition Ingredients
BCC Research LLC
Mon, 31 August 2026 at 4:25 pm GMT+5:30
4 min read
“The global market is forecast to grow from $39.8 billion in 2026 to $53.4 billion by 2031 at a 6.1% CAGR as animal nutrition, pharmaceuticals and sustainable bio-based production drive demand for amino acids, enzymes, organic acids and vitamins.”
Boston, Aug. 31, 2026 (GLOBE NEWSWIRE) — The global market for fermentation ingredients is projected to grow from $39.8 billion in 2026 to $53.4 billion by 2031, at a compound annual growth rate (CAGR) of 6.1% over the forecast period. This growth trajectory is detailed in BCC Research’s latest report, Global Markets for Fermentation Ingredients, which identifies structural demand across animal nutrition, pharmaceuticals, food fortification, and industrial biotechnology as the principal forces reshaping the competitive landscape.
• Market size and growth: The global fermentation ingredients market is valued at $39.8 billion in 2026 and is forecast to reach $53.4 billion by 2031, expanding at a 6.1% CAGR. Long-term growth is anchored by the expanding global livestock, poultry, swine, and aquaculture industries, which increasingly rely on fermentation-derived amino acids — including lysine, threonine, and tryptophan — alongside enzymes and vitamins to improve feed conversion efficiency and production sustainability.• Largest region: Asia Pacific accounts for 38.4% of the global market, underpinned by the region’s dominant role in fermentation-derived fine chemical manufacturing, large-scale animal feed production, and growing pharmaceutical API output — though supply chain concentration in China simultaneously represents both a competitive advantage and a systemic risk.• Pharmaceutical reshoring: Governments across the U.S., Europe, and India are actively investing in domestic fermentation and API manufacturing infrastructure to reduce dependence on Asia-concentrated supply chains. Production Linked Incentive (PLI) schemes in India explicitly target fermentation-derived pharmaceuticals, including Penicillin G and antibiotic intermediates, directly stimulating capacity investment and sustained long-term demand.• Sustainability mandates and bio-based adoption: Global ESG commitments and circular-economy mandates are accelerating the substitution of petrochemical-derived intermediates with fermentation-based alternatives such as succinic acid, itaconic acid, and lactic acid. Simultaneously, enzyme adoption in detergent formulations — enabling low-temperature cleaning and reduced energy consumption — is expanding across textiles, biofuels, and specialty industrial processing.• Emerging technologies: Precision fermentation, synthetic biology and microbial strain engineering, and AI-assisted enzyme design represent the most consequential near-term disruptors. Second-generation biomass fermentation and fermentation-derived bio-based polymers and materials are expanding the addressable market well beyond traditional food and feed applications.• Competitive landscape: The market features a diversified set of global leaders including BASF SE, dsm-firmenich, Ajinomoto Co. Inc., Novonesis, Evonik Industries AG, Cargill Inc., Roquette Frères, CJ CheilJedang Corp., Lonza Group, Corbion, Lesaffre International, ADM, Angel Yeast Co. Ltd., Kerry Group, and Merck KGaA, among others.
